About us

Fifteen coders and analysts with years of experience
Fifteen coders and analysts with years of experience

European Med Tech and IVD Reimbursement Consulting Ltd. (MTRC), is a provider of on-demand and off-the-shelf European reimbursement analyses and strategies for the Med Tech and In-Vitro Diagnostic (IVD) industry as well as for investment companies.

The company is founded by Oleg Borisenko, MD, PhD, who has 12 years of experience in health economics, policy and reimbursement for medical devices and IVDs in Europe. Prior to establishing MTRC, Oleg led market access and health economic activities at Synergus AB, the European Med Tech consultancy.

The scope of our service covers 18 European countries

The scope of our service covers 18 European countries, including Austria, Belgium, Czech Republic, Denmark, England, Finland, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden and Switzerland.

Our team includes several experienced clinical coders and reimbursement analysts, and is complemented by affiliated senior reimbursement consultants from different major countries. Our analysts have an in-depth understanding of the coding and reimbursement landscape and processes in individual countries.

Meet the founder

Oleg Borisenko

Oleg is the Founder and CEO of the MTRC

Oleg has eleven years of experience in the field. His previous positions include Director of Market Access and Health Economics at Synergus AB, Executive Director of ISPOR Russia Chapter and Head of Laboratory for Quality Management in Health Care at the First Moscow State Medical University

During the course of his professional career, Oleg has supervised several hundreds of projects, including reimbursement mappings and strategies, value dossiers, systematic literature reviews, health economic models and within-trial economic evaluations. Oleg has the unique asset of combining both a high-level understanding of a broad range of topics and in-depth knowledge and hands-on experience of major market access-related activities

In the past, Oleg was an active contributor to both the Cochrane Acute Respiratory Infections and Effective Practice and the Organization of Health Care Review Groups. Currently, he is a member of the editorial board of “Journal of Medical Economics” (Informa). Oleg is also an active member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the Patient Classification System International (PCSI) and the Swedish Health Economics Association (SHEA)

From December 2014 Oleg also holds the position of Affiliated Researcher at the Department of Learning, Informatics, Management and Ethics at the Karolinska Institute in Stockholm, where he is involved in studies aimed at improving the Swedish health care system

Our team

Oleg Borisenko, MD, PhD
Founder and CEO

Oleg is a recognized expert in the field of market access for medical devices in Europe. His experience derives from the several hundreds of projects in market access and health economics he has worked on. His specific areas of expertise include European reimbursement pathways, evidence requirements for approval by payers and sound value stories for medical technologies.

Natalia Khaldeeva, MD, PhD
Clinical Coder

Natalia has a 25-year experience in the field of health policy, epidemiology and evidence-based medicine. She has worked in different positions within academia, research organizations and industry, including ViiV HealthCare and Gilead Sciences. Natalia is responsible for clinical coding and reimbursement analysis for a number of European countries at MTRC.

Alina Bakeeva, PharmD
JUNIOR CLINICAL CODER

Alina is a pharmacist by training. She has held positions in multiple industries including pharmacy and clinical research. Prior to joining MTRC, Alina was a medical writer for a Clinical Research Organization. She is now involved in clinical coding at MTRC.

Eugenia Kashcheeva, MSc
Human Resources/Talent Acquisition

Eugenia is a human resource manager by training. She started her career as a psychologist. Afterwards, she decided to improve herself in talent acquisition and career development. She has several years’ experience in human resources in the European and American labor markets. Eugenia is responsible for recruiting, onboarding and career planning at MTRC.

Nadiia Ceylan,  PharmD
JUNIOR CLINICAL CODER

Nadiia is a pharmacist by training. She has experience in the field of medical tourism and hospital management. Nadiia is involved into clinical coding activities at MTRC.

Kirill Kuzmichev,  MD
JUNIOR CLINICAL CODER

Kirill started as a surgeon by training, with a strong interest for public healthcare and international communication in medicine, based on the experience of working internationally for several years, and over time moved to the healthcare organization field with expertise in private insurance. He performs clinical coding activities at MTRC.

Cristina Pineda,  MSc
HEALTH POLICY ANALYST

Cristina obtained a master's diploma in Health Economics and Market Access by the Universidad Carlos III de Madrid. Prior to joining MRTC, she has worked as HEOR for Medtronic Ibérica for two years. She is responsible for market access activities in Spain.

Natalia Alexandrova, PharmD
MARKETING MANAGER

Natalia is a pharmacist by training. She developed her career in a medical field on the role of Medical Representative. Prior to joining MTRC, Natalia possessed an extra education in the field of marketing.  She is now involved in marketing activities at MTRC.

Irina Telegina, MD, PhD
Lead Clinical Coder

Irina started her career as a practicing surgeon in obstetrics and gynaecology, and has gradually developed into a strong expert on evidence-based medicine, European payment systems, classifications of medical procedures and coding practices. Irina leads clinical coding activities at MTRC.

Anna Bogdanova, MD
Market Analyst

Anna started her career as a General Practitioner. Over time, she has developed an interest in marketing, management and business development. Anna is responsible for technology and data analysis at MTRC.

Sava Konstantinovic, MSc
Health Policy Analyst

Sava has obtained a Bachelor's diploma in International Economics, Management and Finance (BIEMF, 2015) at Bocconi University in Milan, after which he obtained a second-level master's diploma in International Healthcare Management, Economics and Policy at SDA Bocconi School of Management, in Milan, Italy. After graduation, Sava had intern positions at Deloitte (financial analysis), Italian hospital (quality and operations) and Roche Pharmaceuticals (market access, pricing and reimbursement). At MTRC, Sava is responsible for market access in Italy, analysis of health technology assessment and evidence requirements for medical technologies in European countries. 

Gemma Seda Gombau,  PhD
HEALTH POLICY ANALYST

Gemma has obtained a master’s diploma in Health Economics and Public Policy in Barcelona Graduate School in Economics, after which she obtained a Ph.D. in Health Care Management in Universitat de Barcelona. She has worked in different positions within academia as well as in research centers. She is currently collaborating with the Catalan Health Department developing primary care studies. At MTRC, Gemma is responsible for market access in Spain. 

Julia Mazur,  MD
JUNIOR CLINICAL CODER

Julia has a specialist degree in Obstetrics/Gynecology, Gynecologic Oncology, and Practical Psychology. She has worked on the position of gynecologic oncologist/oncologist for several years and is finishing her Ph.D. studies in Obstetrics/Gynecology at the moment. Julia is now involved in clinical coding activities at MTRC.

Krzysztof Lach,  MPH, PgDip
HEALTH POLICY ANALYST

Krzysztof holds a master’s degree in Public Health and postgraduate a diploma in Health Economics. He possesses over 11 years of experience in HTA, and market access of drugs and medical technologies, including activities around primary market research, pricing & reimbursement pathways and value communications across various therapeutic areas (e.g., oncology, hematology, cardiology, women’s health), and markets (mostly EU5). He acted as a consultant and a researcher for pharmaceutical companies, large consultancies (Deloitte, The Economist Intelligence Unit), a university hospital (Hospital Clinic of Barcelona) and scientific consortia (The AdHopHTA project) with exposure to both commercial and not-for-profit projects. At MTRC, he is responsible for managing market access and health economics projects across a multitude of therapeutic areas and European markets.

Victoria Ciubotariu, MSc
ADMINISTRATOR/ENGAGEMENT MANAGER

Victoria is a linguist by training; she started her career as a teacher. She also acquired a vast experience in the Executive Assistance and customer satisfaction. At MTRC, Victoria combines the functions of Administrator and Engagement Manager.  

Alena Vazhenina, BSc
MARKETING ASSISTANT

Alena started her career as a Tourism manager; she is studying for a Master’s degree in Economics. At MTRC, she occupies a position of Marketing Assistant.

Our publications

Veličković VM, Borisenko O, Svensson M, Spelman T, Siebert U. Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model. PLoS One. 2018 Sep 27;13(9):e0204643.

O Borisenko, J Müller-Ehmsen, JA Lindenfeld, E Rafflenbeul, C Hamm. An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany. BMC Cardiovascular Disorders, 2018. 18:163.

Borisenko O,  Lukyanov V,  Ahmed A.R. Cost-utility analysis of bariatric surgery. Br J Surg. 2018 Apr 17. doi: 10.1002/bjs.10857.

Borisenko O, Lukyanov V, Debergh I, Dillemans B. Cost-effectiveness analysis of bariatric surgery for morbid obesity in Belgium. J Med Econ. 2018 Jan 10:1-9.

Sanchez-Santos R, Padin EM, Adam D, Borisenko O, Fernandez SE, Dacosta EC, Fernández SG, Vazquez JT, de Adana JCR, de la Cruz Vigo F. Bariatric surgery versus conservative management for morbidly obese patients in Spain: a cost-effectiveness analysis. Expert Rev Pharmacoecon Outcomes Res. 2017 Nov 30:1-10.

Bureau C, Adebayo D, Chalret de Rieu M, Elkrief L, Valla D, Peck-Radosavljevic M, McCune A, Vargas V, Simon-Talero M, Cordoba J, Angeli P, Rosi S, MacDonald S, Malago M, Stepanova M, Younossi ZM, Trepte C, Watson R, Borisenko O, Sun S, Inhaber N, Jalan R. Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenterrandomized controlled study. J Hepatol. 2017 Nov;67(5):940-949.